Bayer HealthCare has submitted applications for marketing authorization to both the European Medicines Agency (EMA) and the Japanese Ministry of Health, Labor and Welfare (MHLW) for VEGF Trap-Eye for the treatment of the neovascular form of age-related macular degeneration (wet AMD).
» more